Ischaemic conditioning and reperfusion injury

Area of Science:

• Cardiology
• Cardiovascular Research
• Translational Medicine

Background:

• Ischaemic preconditioning, discovered 30 years ago, protects the heart from myocardial infarction via brief ischaemia/reperfusion cycles.
• This concept evolved into 'ischaemic conditioning', including direct (preconditioning, postconditioning) and remote (limb) strategies.
• Signalling pathways have been identified, suggesting therapeutic targets for pharmacological manipulation.

Purpose of the Study:

• To review the evolution and clinical translation of ischaemic conditioning and pharmacological cardioprotection strategies.
• To highlight the challenges and successes in applying these findings to acute myocardial infarction and CABG surgery patients.

Main Methods:

• Review of experimental and clinical studies on ischaemic conditioning and pharmacological cardioprotection.
• Analysis of data from large, multicentre, randomized, controlled clinical trials.

Main Results:

• Numerous experimental cardioprotection strategies have been tested clinically with disappointing results.
• No effective cardioprotective therapy is currently standard in clinical practice for acute myocardial infarction.
• Several therapies show promise in reducing infarct size and improving outcomes in ischaemic heart disease.

Conclusions:

• Translating experimental cardioprotection into patient benefit faces significant challenges.
• Further research and well-designed clinical trials are needed to realize the potential of cardioprotective therapies.
• Promising cardioprotective strategies exist, offering hope for improved patient outcomes in ischaemic heart disease.